Overview
Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2025-07-01
2025-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The primary objective of the study is to evaluate the vasodilative effect of subcutaneous nitroglycerin to prevent radial arterial occlusion(RAO) after removal of the radial arterial catheter in pediatric patients. The hypothesis of this study is that subcutaneous nitroglycerin will decrease the incidence of radial arterial occlusion after radial arterial catheter removal in pediatric patients by increasing the radial artery size and improving the first-attempt success rate of radial artery cannulation. This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of subcutaneous nitroglycerin and saline on radial artery cannulation and catheter removal in pediatric patients. Prior to the procedure, each patient will be randomized into either the control arm, saline, or the study arm, nitroglycerin.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Seoul National University HospitalTreatments:
Nitroglycerin
Criteria
Inclusion Criteria:- Patients undergoing General anesthesia
- Patients in the Intensive care unit
- Arterial cannulation for hemodynamic monitoring, or multiple blood sample
Exclusion Criteria:
- Unstable vital signs, significant arrhythmia or hypotension, Shock
- High risk of peripheral ischemia
- Skin disease, infection, hematoma, recent cannulation at the radial artery
- History of anaphylaxis to nitroglycerin